从一团糟到米其林指南：卡介苗治疗非肌层浸润性膀胱癌的后续试验 - Suppr | 超能文献

From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer.

作者信息

Shah Ankeet, Grimberg Dominic C, Inman Brant A

机构信息

Duke Cancer Institute, Division of Urology, Duke University Medical Center, Durham, NC, USA.

Duke Cancer Institute, Division of Urology, Duke University Medical Center, Durham, NC, USA.

出版信息

Eur Urol. 2020 Sep;78(3):400-401. doi: 10.1016/j.eururo.2020.03.022. Epub 2020 Apr 14.

DOI:10.1016/j.eururo.2020.03.022

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

From Dog's Breakfast to Michelin Guide: Post-bacillus Calmette-Guérin Trials in Non-muscle-invasive Bladder Cancer.从一团糟到米其林指南：卡介苗治疗非肌层浸润性膀胱癌的后续试验

Eur Urol. 2020 Sep;78(3):400-401. doi: 10.1016/j.eururo.2020.03.022. Epub 2020 Apr 14.

2

Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.荷兰合作试验最新情况：丝裂霉素与卡介苗-蒂策株菌对比卡介苗-荷兰国家公共卫生与环境研究所菌株治疗pTA-pT1期乳头状癌及膀胱原位癌患者。荷兰东南部合作泌尿外科组

Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.

3

Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.关于以下内容的编辑评论：与短期膀胱内化疗及卡介苗（BCG）短期治疗相比，长期膀胱内辅助化疗可进一步降低非肌层浸润性膀胱癌患者的复发率。

Eur Urol. 2007 Oct;52(4):1129-30. doi: 10.1016/j.eururo.2007.02.064.

4

Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin.经卡介苗膀胱内灌注后非肌层浸润性膀胱癌的膀胱保留治疗疗效的系统评价

Eur Urol. 2020 Sep;78(3):387-399. doi: 10.1016/j.eururo.2020.02.012. Epub 2020 Mar 4.

5

Bacillus Calmette-Guérin treatment of non-muscle invasive bladder cancer.卡介苗治疗非肌肉浸润性膀胱癌。

Int J Urol. 2011 Feb;18(2):113-20. doi: 10.1111/j.1442-2042.2010.02678.x. Epub 2010 Nov 22.

6

Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.经尿道治疗非肌肉浸润性膀胱癌：系统评价和荟萃分析。

J Urol. 2017 May;197(5):1189-1199. doi: 10.1016/j.juro.2016.12.090. Epub 2016 Dec 24.

7

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993).序贯膀胱内顺铂化疗联合卡介苗与单纯卡介苗免疫治疗表浅膀胱癌的随机 2 期 EORTC 泌尿生殖系肿瘤研究组临床试验（30993）

Eur Urol. 2011 Mar;59(3):438-46. doi: 10.1016/j.eururo.2010.11.038. Epub 2010 Dec 7.

8

The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.经膀胱内卡介苗治疗的非肌肉浸润性膀胱癌患者，再次经尿道电切术对复发率和进展率的影响。

J Urol. 2014 Feb;191(2):341-5. doi: 10.1016/j.juro.2013.08.022. Epub 2013 Aug 20.

9

The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder.性别对卡介苗治疗非肌肉浸润性膀胱癌患者的疗效的影响。

BJU Int. 2010 Aug;106(3):357-61. doi: 10.1111/j.1464-410X.2009.09137.x. Epub 2009 Dec 11.

10

Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.与短期膀胱内化疗以及非肌层浸润性膀胱癌患者的短期卡介苗（BCG）治疗相比，长期膀胱内辅助化疗可进一步降低复发率。

Eur Urol. 2007 Oct;52(4):1123-29. doi: 10.1016/j.eururo.2007.02.063. Epub 2007 Mar 12.

引用本文的文献

1

Exploring radiotherapy combined with a radiosensitizer for Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ.探索放疗联合放射增敏剂治疗卡介苗无反应的原位癌非肌层浸润性膀胱癌。

Transl Androl Urol. 2024 Nov 30;13(11):2354-2357. doi: 10.21037/tau-24-480. Epub 2024 Nov 28.

2

Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in three-dimensional bio-printed bladder cancer-on-a-chip and orthotopic mouse model.含 dltA 的重组卡介苗在三维生物打印膀胱癌芯片和原位小鼠模型中的疗效。

Investig Clin Urol. 2023 May;64(3):296-305. doi: 10.4111/icu.20220293.